Effect of switching to teneligliptin from other dipeptidyl peptidase‐4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease.
Saved in:
| Title: | Effect of switching to teneligliptin from other dipeptidyl peptidase‐4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease. |
|---|---|
| Authors: | Kitada, Munehiro1,2 (AUTHOR), Ogura, Yoshio1 (AUTHOR), Nitta, Kyoko1 (AUTHOR), Fujii, Mizue1 (AUTHOR), Kanasaki, Keizo1 (AUTHOR), Konishi, Kazunori1 (AUTHOR), Iida, Yasuo3 (AUTHOR), Nakagawa, Atsushi1 (AUTHOR), Koya, Daisuke1,2 (AUTHOR) koya0516@kanazawa-med.ac.jp |
| Source: | Journal of Diabetes Investigation. May2019, Vol. 10 Issue 3, p706-713. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20401116 |
|---|---|
| DOI: | 10.1111/jdi.12917 |
